The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Mechanisms for Racial and Ethnic Disparities in Glycemic Control in Middle-aged and Older Americans in the Health and Retirement Study
Open accessAbstract
BACKGROUND: Mechanisms for racial/ethnic disparities in glycemic control are poorly understood. METHODS: A nationally representative sample of 1901 respondents 55 years or older with diabetes mellitus completed a mailed survey in 2003; 1233 respondents completed valid at-home hemoglobin A(1c) (HbA(1c)) kits. We constructed multivariate regression models with survey weights to examine racial/ethnic differences in HbA(1c) control and to explore the association of HbA(1c) level with sociodemographic and clinical factors, access to and quality of diabetes health care, and self-management behaviors and attitudes. RESULTS: There were no significant racial/ethnic differences in HbA(1c) levels in respondents not taking antihyperglycemic medications. In 1034 respondents taking medications, the mean HbA(1c) value (expressed as percentage of total hemoglobin) was 8.07% in black respondents and 8.14% in Latino respondents compared with 7.22% in white respondents (P < .001). Black respondents had worse medication adherence than white respondents, and Latino respondents had more diabetes-specific emotional distress (P < .001). Adjusting for hypothesized mechanisms accounted for 14.0% of the higher HbA(1c) levels in black respondents and 19.0% in Latinos, with the full model explaining 22.0% of the variance. Besides black and Latino ethnicity, only insulin use (P < .001), age younger than 65 years (P = .007), longer diabetes duration (P = .004), and lower self-reported medication adherence (P = .04) were independently associated with higher HbA(1c) levels. CONCLUSIONS: Latino and African American respondents had worse glycemic control than white respondents. Socioeconomic, clinical, health care, and self-management measures explained approximately a fifth of the HbA(1c) differences. One potentially modifiable factor for which there were racial disparities--medication adherence--was among the most significant independent predictors of glycemic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unequal treatment: confronting racial and ethnic disparities in health care
(2003) · Choice Reviews Online · doi:10.5860/choice.40-5843 · Cited by 7,043
The summary of diabetes self-care activities measure: results from 7 studies and a revised scale.
Toobert, D. J., Hampson, S. E., & Glasgow, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.943 · Cited by 2,561
Assessment of Diabetes-Related Distress
Polonsky, W. H., Anderson, B. J., Lohrer, P. A., Welch, G., Jacobson, A. M., Aponte, J. E., & Schwartz, C. E. (1995) · Diabetes Care · doi:10.2337/diacare.18.6.754 · Cited by 1,497
Patient-Physician Racial Concordance and the Perceived Quality and Use of Health Care
Saha, S., Komaromy, M., Koepsell, T. D., & Bindman, A. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.997 · Cited by 1,125
Ethnic disparities in diabetic complications in an insured population
Karter, A. J. (2002) · JAMA · doi:10.1001/jama.287.19.2519 · Cited by 840 · cited 1×
“The clusters were added to the model with race/ethnicity in the following order: (1) sociodemographic variables of age, sex, education, and annual household income; (2) clinical variables of diabetes duration, antihyperglycemic regimen, diabetes comorbidities, and depressive symptoms; ( 3 ) health care access and qual…”
MethodContribution of major diseases to disparities in mortality.
Wong, M. D., Shapiro, M. F., Boscardin, W. J., & Ettner, S. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa012979 · Cited by 774
Heisler, M., Bouknight, R. R., Hayward, R. A., Smith, D. M., & Kerr, E. A. (2002) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2002.10905.x · Cited by 717
Self-citationPiette, J. D., Heisler, M., & Wagner, T. H. (2004) · American Journal of Public Health · doi:10.2105/ajph.94.10.1782 · Cited by 349
Self-citationQuality of Diabetes Care in U.S. Academic Medical Centers
Grant, R. W., Buse, J. B., Meigs, J. B., & for the University HealthSystem Consortium (UHC) Diabetes Benchmarking Project Team (2005) · Diabetes Care · doi:10.2337/diacare.28.2.337 · Cited by 311
Estimated benefits of glycemic control in microvascular complications in type 2 diabetes
Vijan, S., Hofer, T. P., & Hayward, R. A. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-9-199711010-00003 · Cited by 228 · cited 1×
“0% of total hemoglobin).(20,37) Results did not differ significantly using Table 1.”
ResultChin, M. H., Zhang, J. X., & Merrell, K. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1090 · Cited by 174
Cited by
Race/Ethnic Difference in Diabetes and Diabetic Complications
Spanakis, E. K., & Golden, S. H. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0421-9 · Cited by 632
A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes
Asche, C., LaFleur, J., & Conner, C. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.01.019 · Cited by 420
Golden, S. H., Brown, A., Cauley, J. A., Chin, M. H., Gary-Webb, T. L., Kim, C., Sosa, J. A., Sumner, A. E., & Anton, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2043 · Cited by 405
Diabetes Control With Reciprocal Peer Support Versus Nurse Care Management: A Randomized Trial
Heisler, M., Vijan, S., Makki, F., & Piette, J. D. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-8-201010190-00007 · Cited by 366
Self-citationSpencer, M. S., Rosland, A.-M., Kieffer, E. C., Sinco, B. R., Valerio, M., Palmisano, G., Anderson, M., Guzman, J. R., & Heisler, M. (2011) · American Journal of Public Health · doi:10.2105/ajph.2010.300106 · Cited by 357
Self-citation
Metadata
- Authors
- Heisler, M.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2007-09-24
- Volume
- 167
- Issue
- 17
- Pages
- 1853
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2132540944
- Cited by
- 237
- References
- 11
- FWCI
- 10.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.